• Haemonetics received FDA approval for its PerQseal Elite vascular closure system for large-bore arterial procedures.
• The approval expands its US portfolio of closure devices for structural heart and endovascular procedures.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Haemonetics Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610191615PR_NEWS_USPR_____NE75733) on October 19, 2026, and is solely responsible for the information contained therein.